Search Within

Hematologic Malignancies Research

Formats
  1. Journal Article (1545)
  2. Meeting Abstract (1260)
  3. Review (76)
  4. Editorial (35)
  5. Book Section (32)
  6. Research Letter (26)
  7. Conference Paper (15)
  8. Correspondence (8)
  9. Guidelines (4)
  10. Miscellaneous (3)
  11. Book Whole (1)
Groups
  1. Center for Hematologic Malignancies (3005)
  2. GSK Faculty (2450)
  3. Department of Medicine (2318)
  4. Hematologic Malignancies, Division of (2120)
  5. Sloan Kettering Institute Faculty (2052)
  6. Molecular Pharmacology and Chemistry Program Faculty (1632)

More Groups

People
  1. Michel Sadelain (586)
  2. David Scheinberg (502)
  3. Alexander Lesokhin (381)
  4. Carl Landgren (336)
  5. Renier Brentjens (286)
  6. Gabriela Chiosis (281)

More People

Years
  1. 2025 (64)
  2. 2024 (131)
  3. 2023 (175)
  4. 2022 (126)
  5. 2021 (154)
  6. 2020 (173)

More Years

Publications
  1. Blood (660)
  2. Cancer Research (117)
  3. Journal of Clinical Oncology (112)
  4. Clinical Lymphoma, Myeloma and Leukemia (84)
  5. Biology of Blood and Marrow Transplantation (80)
  6. Molecular Therapy (68)

More Publications

Publishers
  1. American Society of Hematology (700)
  2. Nature Publishing Group (375)
  3. Elsevier Inc. (291)
  4. American Association for Cancer Research (245)
  5. American Society of Clinical Oncology (116)
  6. Cell Press (116)

More Publishers

Results (3005)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Circulating immunologic markers and risk of multiple myeloma and its precursor disease: A nested case-control study
    Meeting Abstract

    Hofmann, J. N.; Landgren, O.; Katki, H.; Kemp, T.; Santo, L.; McShane, C.; Lan, Q.; Rothman, N.; Pinto, L.; Pfeiffer, R.; more...
    Cancer Research (2018)

    Fulltext@MSK | Save
  • Nrf2-mediated oxidative stress response is altered during acquired resistance to the proteasome inhibitor, oprozomib, in multiple myeloma
    Meeting Abstract

    Gaikwad, S. M.; Zingone, A.; Michalowski, A.; Najera, S.; Quintanilla-Artega, A.; Gorjifard, S.; Simmons, J.; Watson, N.; Landgren, O.; Huang, J.; more...
    Cancer Research (2018)

    Fulltext@MSK | Save
  • Functional proteomics for precise cancer diagnosis and therapy using the MSK Quantitative Cancer Proteomics Atlas
    Meeting Abstract

    Cifani, P.; Dogan, A.; Solit, D. B.; Kentsis, A.
    Cancer Research (2018)

    Fulltext@MSK | Save
  • Donor-specific antibodies, immunoglobulin-free light chains, and BAFF levels in relation to risk of late-onset PTLD in liver recipients
    Journal Article

    Engels, E. A.; Jennings, L. W.; Everly, M. J.; Landgren, O.; Murata, K.; Yanik, E. L.; Pfeiffer, R. M.; Onaca, N.; Klintmalm, G. B.
    Transplantation Direct (2018)

    Fulltext@MSK | Save
  • Germline SDHA mutations in children and adults with cancer
    Journal Article

    Dubard Gault, M.; Mandelker, D.; Delair, D.; Stewart, C. R.; Kemel, Y.; Sheehan, M. R.; Siegel, B.; Kennedy, J.; Marcell, V.; Arnold, A.; more...
    Cold Spring Harbor Molecular Case Studies (2018)

    Fulltext@MSK | Save
  • Development of citrullinated-vimentin-specific CAR for targeting Tregs to treat autoimmune rheumatoid arthritis
    Meeting Abstract

    Raffin, C.; Zhou, Y.; Piccoli, L.; Lanzavecchia, A.; Sadelain, M.; Tareen, S. U.; Fontenot, J. D.; Bluestone, J. A.
    Journal of Immunology (2018)

    Fulltext@MSK | Save
  • A novel iPSC model reveals a role for RUNX1 in the maintenance of AML leukemia stem cells
    Meeting Abstract

    Wesely, J.; Kotini, A. G.; Georgomanoli, M.; Luo, H.; Yuan, H.; Izzo, F.; Landau, D. A.; Leslie, C.; Kharas, M. G.; Papapetrou, E. P.
    Blood (2018)

    Fulltext@MSK | Save
  • The role of HLA-E, polymorphism in acute leukemia patients receiving a 10/10 HLA matched unrelated HSCT
    Meeting Abstract

    Tsamadou, C.; Wang, T.; Furst, D.; Lee, S. J.; Spellman, S. R.; Fleischhauer, K.; Hsu, K. C.; Paczesny, S.; Verneris, M. R.; Neuchel, C.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Functional profiling of patient AML stem cells reveals mechanisms of epigenetic plasticity controlling therapy resistance
    Meeting Abstract

    Takao, S.; Koche, R.; Cifani, P.; Ser, Z.; Kentsis, A.
    Blood (2018)

    Fulltext@MSK | Save
  • CAR T cell therapy targeting G protein-coupled receptor class C group 5 member D (GPRC5D), a novel target for the immunotherapy of multiple myeloma
    Meeting Abstract

    Smith, E. L.; Harrington, K.; Staehr, M.; Masakayan, R.; Jones, J.; Long, T.; Ghoddusi, M.; Purdon, T. J.; Do, T.; Wang, X.; more...
    Blood (2018)

    Fulltext@MSK | Save